secwatch / observer
8-K filed October 13, 2023, 7:59 PM ET CIK 0001840904
leadership confidence high sentiment neutral materiality 0.20

ATAI CFO Stephen Bardin on parental leave; CAO Anne Johnson named interim CFO

ATAI Life Sciences N.V.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Anne Johnson

Interim Chief Financial Officer
ATAI Life Sciences N.V.
Effective
2023-10-13
Filed
October 13, 2023, 7:59 PM ET
On October 13, 2023, the Supervisory Board of Directors (the “Board”) of the Company temporarily appointed Ms. Anne Johnson, the Company’s Chief Accounting Officer (principal accounting officer), to act as the Company’s Interim Chief Financial Officer (principal financial officer) while Mr. Stephen Bardin is on parental leave.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Anne Johnson was appointed as Interim Chief Financial Officer at ATAI Life Sciences N.V..

Action
appointed
Role
Interim Chief Financial Officer
Exact text from the filing
On October 13, 2023, the Supervisory Board of Directors (the “Board”) of the Company temporarily appointed Ms. Anne Johnson, the Company’s Chief Accounting Officer (principal accounting officer), to act as the Company’s Interim Chief Financial Officer (principal financial officer) while Mr. Stephen Bardin is on parental leave.
View on SEC.gov
Source: SEC EDGAR
accession 0001140361-23-048183
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.